Diagnostic performance and longitudinal analysis of fungal biomarkers in COVID-19 associated pulmonary aspergillosis

•Galactomannan lateral flow assay (GM-LFA) is a reliable test for COVID-19 associated pulmonary aspergillosis (CAPA) diagnosis.•Diagnostic performances of both serum and nondirected bronchial lavage GM-LFA tend to decrease in the following days after CAPA diagnosis.•In multivariate joint model analysis, doubling in serum GM-ELISA levels is associated with a 3.07-fold increased risk of death.